| Phase II study of lutetium-177–labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer ST Tagawa, MI Milowsky, M Morris, S Vallabhajosula, P Christos, ... Clinical cancer research 19 (18), 5182-5191, 2013 | 479 | 2013 |
| Mice cloned from olfactory sensory neurons K Eggan, K Baldwin, M Tackett, J Osborne, J Gogos, A Chess, R Axel, ... Nature 428 (6978), 44-49, 2004 | 469 | 2004 |
| Spontaneous neural activity is required for the establishment and maintenance of the olfactory sensory map CR Yu, J Power, G Barnea, S O'Donnell, HEV Brown, J Osborne, R Axel, ... Neuron 42 (4), 553-566, 2004 | 441 | 2004 |
| Association of black race with prostate cancer–specific and other-cause mortality RT Dess, HE Hartman, BA Mahal, PD Soni, WC Jackson, MR Cooperberg, ... JAMA oncology 5 (7), 975-983, 2019 | 344 | 2019 |
| Racial/ethnic disparities in genomic sequencing DE Spratt, T Chan, L Waldron, C Speers, FY Feng, OO Ogunwobi, ... JAMA oncology 2 (8), 1070-1074, 2016 | 284 | 2016 |
| A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer N Pandit-Taskar, JA O'Donoghue, JC Durack, SK Lyashchenko, ... Clinical Cancer Research 21 (23), 5277-5285, 2015 | 201 | 2015 |
| Genetic ablation and restoration of the olfactory topographic map JA Gogos, J Osborne, A Nemes, M Mendelsohn, R Axel Cell 103 (4), 609-620, 2000 | 179 | 2000 |
| 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic … S Vallabhajosula, A Nikolopoulou, JW Babich, JR Osborne, ST Tagawa, ... Journal of Nuclear Medicine 55 (11), 1791-1798, 2014 | 170 | 2014 |
| Targeted elimination of prostate cancer by genetically directed human T lymphocytes TPF Gade, W Hassen, E Santos, G Gunset, A Saudemont, MC Gong, ... Cancer research 65 (19), 9080-9088, 2005 | 170 | 2005 |
| Anti–prostate‐Specific membrane antigen‐based radioimmunotherapy for prostate cancer ST Tagawa, H Beltran, S Vallabhajosula, SJ Goldsmith, J Osborne, ... Cancer 116 (S4), 1075-1083, 2010 | 169 | 2010 |
| 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer N Pandit-Taskar, JA O’Donoghue, V Beylergil, S Lyashchenko, S Ruan, ... European journal of nuclear medicine and molecular imaging 41, 2093-2105, 2014 | 153 | 2014 |
| Prostate-specific membrane antigen-based imaging JR Osborne, NH Akhtar, S Vallabhajosula, A Anand, K Deh, ST Tagawa Urologic Oncology: Seminars and Original Investigations 31 (2), 144-154, 2013 | 153 | 2013 |
| Altered biodistribution of radiopharmaceuticals: role of radiochemical/pharmaceutical purity, physiological, and pharmacologic factors S Vallabhajosula, RP Killeen, JR Osborne Seminars in nuclear medicine 40 (4), 220-241, 2010 | 153 | 2010 |
| 18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers N Palaskas, SM Larson, N Schultz, E Komisopoulou, J Wong, D Rohle, ... Cancer research 71 (15), 5164-5174, 2011 | 145 | 2011 |
| 18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis JR Osborne, E Port, M Gonen, A Doane, H Yeung, W Gerald, JB Cook, ... Journal of Nuclear Medicine 51 (4), 543-550, 2010 | 126 | 2010 |
| Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations FW Huang, JM Mosquera, A Garofalo, C Oh, M Baco, A Amin-Mansour, ... Cancer discovery 7 (9), 973-983, 2017 | 120 | 2017 |
| Phase 1/2 study of fractionated dose lutetium‐177–labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic … ST Tagawa, S Vallabhajosula, PJ Christos, YS Jhanwar, JS Batra, L Lam, ... Cancer 125 (15), 2561-2569, 2019 | 118 | 2019 |
| Prostate Specific Membrane Antigen-Based Therapeutics ST Tagawa, JR Osborne, S Vallabhajosula, SJ Goldsmith, NH Bander Prostate Cancer: A Comprehensive Perspective, 459-466, 2013 | 113 | 2013 |
| Comparison of 18F-FDG PET/CT for systemic staging of newly diagnosed invasive lobular carcinoma versus invasive ductal carcinoma MP Hogan, DA Goldman, B Dashevsky, CC Riedl, M Gönen, JR Osborne, ... Journal of Nuclear Medicine 56 (11), 1674-1680, 2015 | 109 | 2015 |
| A Prospective Pilot Study of 89Zr-J591/Prostate Specific Membrane Antigen Positron Emission Tomography in Men with Localized Prostate Cancer Undergoing … JR Osborne, DA Green, DE Spratt, S Lyashchenko, SB Fareedy, ... The Journal of urology 191 (5), 1439-1445, 2014 | 103 | 2014 |
